BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11592106)

  • 1. Upregulation of tenascin and TGFbeta production in a type II alveolar epithelial cell line by antibody against a pulmonary auto-antigen.
    Wallace WA; Howie SE
    J Pathol; 2001 Sep; 195(2):251-6. PubMed ID: 11592106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease.
    Wallace WA; Howie SE
    J Pathol; 1999 Mar; 187(4):475-80. PubMed ID: 10398109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.
    Wallace WA; Schofield JA; Lamb D; Howie SE
    Thorax; 1994 Nov; 49(11):1139-45. PubMed ID: 7831631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system.
    Qian X; Agematsu K; Freeman GJ; Tagawa Y; Sugane K; Hayashi T
    Eur J Immunol; 2006 Apr; 36(4):906-18. PubMed ID: 16552709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 increases CD21-dependent infection of pulmonary alveolar epithelial type II cells by EBV.
    Malizia AP; Egan JJ; Doran PP
    Mol Immunol; 2009 May; 46(8-9):1905-10. PubMed ID: 19193442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis.
    Wallace WA; Howie SE; Lamb D; Salter DM
    J Pathol; 1995 Apr; 175(4):415-20. PubMed ID: 7540684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells.
    Abonyo BO; Lebby KD; Tonry JH; Ahmad M; Heiman AS
    Cytokine; 2006 Dec; 36(5-6):237-44. PubMed ID: 17350279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release.
    Salib RJ; Lau LC; Howarth PH
    Clin Exp Allergy; 2005 Jun; 35(6):811-9. PubMed ID: 15969674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo.
    Sullivan DE; Ferris M; Pociask D; Brody AR
    J Immunotoxicol; 2008 Apr; 5(2):145-9. PubMed ID: 18569384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis.
    Pechkovsky DV; Goldmann T; Vollmer E; Müller-Quernheim J; Zissel G
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):30-8. PubMed ID: 16420594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
    Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interleukin-8 and growth-regulated oncogene-alpha in the chemotactic migration of all-trans retinoic acid-treated promyelocytic leukemic cells toward alveolar epithelial cells.
    Tsai WH; Hsu HC; Lin CC; Ho CK; Kou YR
    Crit Care Med; 2007 Mar; 35(3):879-85. PubMed ID: 17235257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells.
    Lochrie JD; Phillips K; Tonner E; Flint DJ; Allan GJ; Price NC; Beattie J
    J Cell Physiol; 2006 May; 207(2):471-9. PubMed ID: 16419030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II collagen modulates the composition of extracellular matrix synthesized by articular chondrocytes.
    Qi WN; Scully SP
    J Orthop Res; 2003 Mar; 21(2):282-9. PubMed ID: 12568960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway.
    Kwong KY; Literat A; Zhu NL; Huang HH; Li C; Jones CA; Minoo P
    Life Sci; 2004 Apr; 74(24):2941-57. PubMed ID: 15051419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa.
    Di Sabatino A; Pickard KM; Rampton D; Kruidenier L; Rovedatti L; Leakey NA; Corazza GR; Monteleone G; MacDonald TT
    Gut; 2008 May; 57(5):605-12. PubMed ID: 18178611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IL-6 and TNF-alpha in human alveolar epithelial cells is induced by invading, but not by adhering, Legionella pneumophila.
    Chang B; Amemura-Maekawa J; Kura F; Kawamura I; Watanabe H
    Microb Pathog; 2004 Dec; 37(6):295-302. PubMed ID: 15619425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A factor secreted by a human pulmonary alveolar epithelial-like cell line blocks T-cell proliferation between G1 and S phase.
    Paine R; Chavis A; Gaposchkin D; Christensen P; Mody CH; Turka LA; Toews GB
    Am J Respir Cell Mol Biol; 1992 Jun; 6(6):658-66. PubMed ID: 1591014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinoic acid inhibits tumor necrosis factor-alpha induced injury in human lung epithelial cells].
    Zhao YX; Wang L; Liu D; Yu RJ
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3358-61. PubMed ID: 17313834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.